ロード中...
Anti-Drug Antibodies: Emerging Approaches to Predict, Reduce or Reverse Biotherapeutic Immunogenicity
The development of anti-drug antibodies (ADAs) following administration of biotherapeutics to patients is a vexing problem that is attracting increasing attention from pharmaceutical and biotechnology companies. This serious clinical problem is also spawning creative research into novel approaches t...
保存先:
| 出版年: | Antibodies (Basel) |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6698869/ https://ncbi.nlm.nih.gov/pubmed/31544871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antib7020019 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|